Dr. Manjunath S Vadmal , MD
Dermatology โข Burbank, CA
2720 W Magnolia Blvd
Burbank, CA 915053034
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 4, 2006; this date does not establish years in practice.
-
Published CMS data list 22,045 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 88305 โ Pathology examination of tissue using a microscope, intermediate complexity: 8,802 service units.
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 5,643 service units.
- 99213 โ Established patient outpatient office visit: 1,623 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 35 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,620 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole โ 259 prescription fills, including refills.
- Clobetasol Propionate โ 157 prescription fills, including refills.
- Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) โ 132 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 37 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Dermatology in Burbank, CA (2024, 14 clinicians with data). Median for this group: 1,497. Middle half: 359 to 3,436.
More Medicare Part B services than 95% of clinicians listed under Dermatology in California (2024, 1,173 clinicians with data). Median for this group: 2,242. Middle half: 930 to 4,815.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 19,444 in 2020 to 22,045 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
2720 W Magnolia Blvd
Burbank, CA 915053034
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Valencia, CA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 3 distinct group names: American Skin Institute Inc; Contour Dermatology And Cosmetic Surgery Medical Center Apc; Skin And Beauty Center Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
1984
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
5,500 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $1,416,792 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $1,079,668 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
1,836 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$543,118 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,320.69 across 231 records.
By nature of payment
- Food and Beverage: $4,311.04 across 230 records.
- Education: $9.65 across 1 record.
Reporting-company totals (3 largest of 25)
- LEO Pharma Inc.: $503.16 across 20 records.
- Novartis Pharmaceuticals Corporation: $475.46 across 18 records.
- Galderma Laboratories, L.P.: $455.07 across 38 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
42 years (graduated 1984)
CMS Doctors and Clinicians data list 1984 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Vadmal has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Vadmal as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Burbank and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Dermatology in Burbank, CA (2024, 14 clinicians with data). Median for this group: 1,497. Middle half: 359 to 3,436.
More Medicare Part B services than 95% of clinicians listed under Dermatology in California (2024, 1,173 clinicians with data). Median for this group: 2,242. Middle half: 930 to 4,815.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Dermatology in Burbank, CA (2024, 14 clinicians with data). Median for this group: $124,851. Middle half: $31,618 to $277,961.
A higher Medicare-allowed amount than 95% of clinicians listed under Dermatology in California (2024, 1,173 clinicians with data). Median for this group: $174,353. Middle half: $66,544 to $372,919.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Dermatology in Burbank, CA (2024, 14 clinicians with data). Median for this group: $88,775. Middle half: $22,832 to $192,378.
A higher Medicare payment amount than 95% of clinicians listed under Dermatology in California (2024, 1,173 clinicians with data). Median for this group: $125,258. Middle half: $46,902 to $276,443.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Dermatology in Burbank, CA (2024, 14 clinicians with data). Median for this group: 418. Middle half: 269 to 1,041.
More Part D prescriptions than 90% of clinicians listed under Dermatology in California (2024, 1,488 clinicians with data). Median for this group: 461. Middle half: 181 to 901.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Dermatology in Burbank, CA (2024, 14 clinicians with data). Median for this group: $32,883. Middle half: $9,647 to $242,116.
A higher Part D drug cost than 85% of clinicians listed under Dermatology in California (2024, 1,488 clinicians with data). Median for this group: $65,207. Middle half: $5,984 to $248,204.
15 active clinicians are listed under Dermatology with a practice address in Burbank, CA (2,106 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Burbank
46.7% of these 15 clinicians have the CMS telehealth indicator.
100% of these 15 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 13% from 19,444 in 2020 to 22,045 in 2024.
- 2020: 19,444
- 2021: 17,971
- 2022: 10,926
- 2023: 13,406
- 2024: 22,045
-
Medicare-allowed amount
Medicare-allowed amount increased 26% from $1,120,026 in 2020 to $1,416,792 in 2024.
- 2020: $1,120,026
- 2021: $995,748
- 2022: $546,169
- 2023: $731,214
- 2024: $1,416,792
-
Paid by Medicare
Paid by Medicare increased 24% from $867,228 in 2020 to $1,079,668 in 2024.
- 2020: $867,228
- 2021: $763,963
- 2022: $406,875
- 2023: $540,584
- 2024: $1,079,668
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 88% from 864 in 2020 to 1,620 in 2024.
- 2020: 864
- 2021: 913
- 2022: 923
- 2023: 1,299
- 2024: 1,620
-
30-day fills
30-day fills increased 93% from 953 in 2020 to 1,836 in 2024.
- 2020: 953
- 2021: 998
- 2022: 1,024
- 2023: 1,440
- 2024: 1,836
-
Part D drug cost
Part D drug cost increased 224% from $167,782 in 2020 to $543,118 in 2024.
- 2020: $167,782
- 2021: $79,296
- 2022: $59,616
- 2023: $234,690
- 2024: $543,118
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 14% from $3,805.46 in 2021 to $4,320.69 in 2025.
- 2021: $3,805.46
- 2022: $6,371.88
- 2023: $11,424.29
- 2024: $11,639.83
- 2025: $4,320.69
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 231 records totaling $4,320.69.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Organon LLC |
Food and Beverage
In-kind items and services
|
VTAMA | General | $88.58 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $67.48 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $62.13 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ANZUPGO | General | $52.45 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $49.03 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $48.43 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $46.36 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $46.16 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $45.89 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $45.53 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $44.90 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $43.01 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
โ | General | $40.13 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.13 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $38.10 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Winlevi | General | $37.89 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $37.78 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.63 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $36.12 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.36 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $34.76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $34.32 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $34.11 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $31.88 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
88305
Pathology examination of tissue using a microscope, intermediate complexity
|
8,802 | 4,679 | $184.97 | $74.21 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
5,643 | 623 | $15.45 | $7.50 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,623 | 915 | $199.90 | $97.45 |
|
17000
Destruction of precancer skin growth, 1 growth
|
1,098 | 685 | $153.49 | $49.96 |
|
11102
Biopsy of related skin growth, first growth
|
752 | 573 | $230.40 | $90.18 |
|
17110
Destruction of skin growth, 1-14 growths
|
703 | 513 | $262.57 | $122.91 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
400 | 89 | $1.97 | $0.89 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
389 | 259 | $380.91 | $186.89 |
|
11103
Biopsy of related skin growth, each additional growth
|
368 | 242 | $114.53 | $55.98 |
|
88304
Pathology examination of tissue using a microscope, moderately low complexity
|
351 | 313 | $133.27 | $48.18 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
319 | 216 | $281.29 | $132.63 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
226 | 226 | $243.89 | $120.44 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
218 | 174 | $125.54 | $60.67 |
|
88312
Special stained specimen slides to identify organisms including interpretation and report
|
180 | 148 | $250.72 | $125.42 |
|
88341
Special stained specimen slides to examine tissue, each additional procedure
|
148 | 48 | $204.97 | $100.54 |
|
96372
Injection of drug or substance under skin or into muscle
|
106 | 42 | $32.01 | $14.09 |
|
17111
Destruction of skin growth, 15 or more growths
|
86 | 61 | $304.89 | $145.69 |
|
88342
Special stained specimen slides to examine tissue, initial procedure
|
74 | 66 | $231.47 | $116.84 |
|
11900
Injection into skin growth, 1-7 growths
|
67 | 53 | $129.83 | $48.67 |
|
17264
Destruction of cancer skin growth of trunk, arms, or legs, 3.1-4.0 cm
|
66 | 53 | $468.84 | $213.19 |
|
17263
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm
|
53 | 45 | $436.29 | $174.41 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
47 | 47 | $363.29 | $170.85 |
|
17283
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm
|
40 | 34 | $544.38 | $251.16 |
|
11104
Punch biopsy, first skin growth
|
35 | 33 | $286.05 | $132.99 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
34 | 34 | $159.48 | $79.19 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 259 | 7,907 | $3,900.45 | 139 |
| Clobetasol Propionate | Clobetasol Propionate | 157 | 4,586 | $15,368.32 | 105 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 132 | 4,115 | $5,257.24 | 91 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 108 | 3,665 | $1,342.96 | 71 |
| Desonide | Desonide | 66 | 1,713 | $2,728.79 | 54 |
| Doxycycline Hyclate | Doxycycline Hyclate | 61 | 1,882 | $648.41 | 34 |
| Mupirocin | Mupirocin | 60 | 1,274 | $331.80 | 51 |
| Ammonium Lactate | Ammonium Lactate | 59 | 1,880 | $1,059.02 | 34 |
| Tacrolimus | Tacrolimus | 51 | 1,583 | $9,205.14 | 32 |
| Doxepin Hcl | Doxepin Hcl | 46 | 1,476 | $500.59 | โ |
| Clindamycin Phosphate | Clindamycin Phosphate | 44 | 1,240 | $2,325.45 | 29 |
| Minoxidil | Minoxidil | 43 | 3,300 | $471.39 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 42 | 1,350 | $449.68 | 20 |
| Vtama | Tapinarof | 38 | 1,185 | $52,371.80 | 21 |
| Ciclopirox | Ciclopirox | 37 | 1,080 | $664.43 | 16 |
| Desoximetasone | Desoximetasone | 37 | 1,089 | $5,282.73 | 23 |
| Tazarotene | Tazarotene | 29 | 840 | $5,921.40 | 13 |
| Dupixent Pen | Dupilumab | 29 | 994 | $144,800.19 | โ |
| Imiquimod | Imiquimod | 24 | 538 | $863.17 | 14 |
| Cephalexin | Cephalexin | 23 | 298 | $830.02 | 19 |
| Tretinoin | Tretinoin | 22 | 735 | $1,314.59 | 18 |
| Pimecrolimus | Pimecrolimus | 21 | 685 | $4,226.52 | 19 |
| Fluocinonide | Fluocinonide | 20 | 560 | $675.59 | 20 |
| Adapalene | Adapalene | 20 | 590 | $1,393.02 | โ |
| Dutasteride | Dutasteride | 20 | 1,470 | $717.09 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2019-12-31NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207ZP0102X
A pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PATHOLOGY
I20040110000213
CA
8527963909
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Contour Dermatology And Cosmetic Surgery Medical Center Apc
42600 Mirage Rd, Rancho Mirage, CA 922704127
Phone: 7604234000
Contour Dermatology And Cosmetic Surgery Medical Center Apc
46080 Jefferson St, La Quinta, CA 922534401
Phone: 7604234000
American Skin Institute Inc
4836 Van Nuys Blvd, Sherman Oaks, CA 914032101
Phone: 8189077546
Skin And Beauty Center Inc
1577 E Chevy Chase Dr, Glendale, CA 912064743
Phone: 8182464936
Skin And Beauty Center Inc
1818 Verdugo Blvd, Glendale, CA 912081444
Phone: 8187903588
Skin And Beauty Center Inc
2220 N Screenland Dr, Burbank, CA 915051137
Phone: 8188428000
Skin And Beauty Center Inc
23501 Cinema Dr, Valencia, CA 913555429
Phone: 6612583811
Skin And Beauty Center Inc
2720 W Magnolia Blvd, Burbank, CA 915053034
Phone: 8188428000
Skin And Beauty Center Inc
9535 Reseda Blvd, Northridge, CA 913246029
Phone: 8188863884
Secondary Practice Locations
23501 Cinema Dr Ste 111
Valencia, CA 913555429
Phone: 8778222223
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.)
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2720 W MAGNOLIA BLVD, BURBANK, CA 915053034 (Tel: 8188428000)
Additional practice office at 23501 Cinema Dr Ste 111, Valencia, CA 913555429
NPI status registered as active in NPPES database
Registered at 191 S BUENA VISTA ST, SUITE 475, BURBANK, CA 915054554 (Tel: 8188428000)
Registered at 8950 W OLYMPIC BLVD, SUITE 171, BEVERLY HILLS, CA 902113561 (Tel: 3239358800)
Recorded as MANJUNATH VADMAL, M.D.
Dermatology (license number reported to NPPES: CA A73000)
NPI status registered as active in NPPES database
Registered at 191 S BUENA VISTA ST, SUITE 475, BURBANK, CA 915054554 (Tel: 8188428000)
Registered at 8950 W OLYMPIC BLVD, SUITE 171, BEVERLY HILLS, CA 902113561 (Tel: 3239358800)
Recorded as MANJUNATH VADMAL, MD
Dermatology (license number reported to NPPES: CA A73000)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Burbank
- Dr. Stuart Shear, MD
- Dr. Rachel Bak, MD
- Dr. Kyle Cheng, MD
- Dr. Iris Ahronowitz, MD
- Dr. Ava Khosraviani, MD
- Dr. Karin Eshagh, MD
More public profiles in California
Directory navigation, in NPI number order.
- Basil Adad, MD Otolaryngology ยท Walnut Creek
- Lanchinh Nguyen, MD Internal Medicine - Gastroenterology ยท Vacaville
- Bella Berzin, MD Internal Medicine ยท Daly City
- Kimberly Cusato, MD Internal Medicine - Gastroenterology ยท Oakland
- Ann Hudacek, DPM Podiatrist ยท Monterey
- Tai-Won Kim, MD Internal Medicine ยท Buena Park
- Karen Lee, MD Psychiatry & Neurology - Child & Adolescent Psychiatry ยท Los Angeles
- Benjamin Orejudos, MD Radiology - Diagnostic Radiology ยท National City
- Maude Scott, PHYSICAL THERAPIST Specialist ยท Palo Alto
- Scott Kamena, OD Optometrist ยท Livermore
- John Lee, MD Internal Medicine - Gastroenterology ยท Orange
- Ninh Nguyen, MD Surgery ยท Orange
Mailing Address
8950 W Olympic Blvd, Suite 171
Beverly Hills, CA 902113561
Phone: 3239358800